All In Biotech

Drug Trial Radar · NCT04620148

TAK-242 in Patients With Acute Alcoholic Hepatitis

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Proof-of-Concept, Phase 2a Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous TAK-242 in Subjects With Acute Alcoholic Hepatitis Causing Decompensation of Alcohol-related Cirrhosis and Acute-on-Chronic Liver Failure

Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

4

Actual

Start

Nov 12, 2020

Primary completion

Mar 31, 2022

Study completion Mar 31, 2022

Sponsor

Lead sponsor
Akaza Bioscience LtdIndustry
Sponsor type
Industry
First posted
Nov 6, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A phase 2a double-blind, randomized, placebo-controlled, multicenter, proof-of-concept study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of TAK-242 in subjects with acute decompensation of alcohol-related cirrhosis due to alcoholic hepatitis resulting in acute-on-chronic liver failure.

Conditions

  • Acute-On-Chronic Liver Failure

Interventions

  • TAK-242Drug

    TAK-242 concentrate solution 80 mg/mL for dilution and infusion

  • PlaceboDrug

    Matching placebo concentrate solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in CLIF-C Acute-on-chronic Liver Failure (CLIF-C ACLF) Score From Baseline to Day 8Time frame: Baseline to Day 8

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Kings College Hospital

    London, United Kingdom

  • Nottingham University Hospital Queen's Medical Centre

    Nottingham, United Kingdom

  • Derriford Hospital

    Plymouth, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.